NCT04055571

Brief Summary

This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, Texas(TX). The investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either investigator's patients or through a national database. Data will be analyzed primarily by the study conductors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Mar 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Mar 2019Jan 2028

Study Start

First participant enrolled

March 5, 2019

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

March 22, 2019

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 13, 2019

Completed
7.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2028

Last Updated

June 10, 2026

Status Verified

January 1, 2026

Enrollment Period

7.9 years

First QC Date

March 22, 2019

Last Update Submit

June 8, 2026

Conditions

Benign or Malignant Pancreatic Diseases

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    Number of patients who have been diagnosed with benign or malignant pancreatic disease

    2005 to 2019

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All past patients who were treated for a particular benign or malignant pancreatic disease process under evaluation from 2005 to present will be included in this study.

You may qualify if:

  • All patients diagnosed and treated for pancreatic diseases, benign or malignant from 2005 to present
  • Age ≥18 years

You may not qualify if:

  • Patients that are not diagnosed with or treated for pancreatic diseases
  • Age \< 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Trinity Surgical Consultants, Methodist Richardson Medical Center

Richardson, Texas, 75082, United States

RECRUITING

Study Officials

  • Dhiresh Jeyarajah, M.D.

    Methodist Richardson Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Crystee Cooper, DHEd

CONTACT

214-947-1280CrysteeCooper@mhd.com

Nitasha Phatak, Ph.D.

CONTACT

214-947-4459NitashaPhatak@mhd.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2019

First Posted

August 13, 2019

Study Start

March 5, 2019

Primary Completion (Estimated)

January 30, 2027

Study Completion (Estimated)

January 30, 2028

Last Updated

June 10, 2026

Record last verified: 2026-01

Locations

US(1)